IL-2/anti-IL-2 antibody complexes augment immune responses to therapeutic cancer vaccines.

Autor: Sobral, Miguel C., Cabizzosu, Laura, Kang, Shawn J., Ruark, Kyle, Najibi, Alex J., Lane, Ryan S., Vitner, Einat, Ijaz, Hamza, Dellacherie, Maxence O., Dacus, Mason T., Tringides, Christina M., de Lázaro, Irene, Pittet, Mikaël J., Müller, Sören, Turley, Shannon J., Mooney, David J.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America; 11/26/2024, Vol. 121 Issue 48, p1-11, 32p